Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
NRC HEALTH
Bear Case (25th pct.)
-23.2% vs price
Base Case (Median)
-9.9% vs price
Bull Case (75th pct.)
5.0% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $22.17 | 5.0% | High (40%) |
| Graham Number | $26.67 | 26.3% | Medium (40%) |
| EV/EBITDA | $10.28 | -51.3% | Medium (20%) |
| EV/FCF | $16.21 | -23.3% | Medium (20%) |
| Earnings Power Value | $19.03 | -9.9% | Medium (50%) |
Based on 5 out of 7 methods, NRC appears fairly valued at the current price of $21.12. The base case fair value of $19.03 implies 9.9% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.